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Abstract
Ensuring parents make an informed decision about their child’s participation in a clinical trial is a challenge for practitioners
as a parent’s comprehension of a trial may differ from that intended by the practitioners responsible for recruitment. We
explored what issues parents consider important when making a decision about participation in a paediatric clinical trial
and their comprehension of these issues to inform future recruitment practice. This qualitative interview and observational
study examined recruitment in four placebo-controlled, double-blind randomised clinical trials of medicines for children.
Audio-recorded trial recruitment discussions between practitioners and parents (N = 41) were matched with semi-structured
interviews with parents (N= 41). When making a decision about trial entry parents considered clinical benefit, child safety,
practicalities of participation, research for the common good, access to medication and randomisation. Within these
prioritised issues parents had specific misunderstandings, which had the potential to influence their decisions. While
parents had many questions and concerns about trial participation which influenced their decision-making, they rarely
voiced these during discussions about the trials with practitioners. Those involved in the recruitment of children to clinical
trials need to be aware of parents’ priorities and the sorts of misunderstandings that can arise with parents. Providing trial
information that is tailored to what parents consider important in making a decision about a clinical trial may improve
recruitment practice and ultimately benefit evidence-based paediatric medicine.
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Introduction
The recognition that clinical trials are essential in developing
safe and effective treatments for children has led to international
policy changes to promote clinical research in paediatrics [1–3].
Despite such developments, there is on-going debate regarding the
conduct of recruitment and consent methods for paediatric clinical
trials at an international level [4–9]. Although parental consent is a
legal and ethical requirement for children to be entered into a trial,
a parent’s comprehension of their child’s involvement in the
clinical trial may differ from that intended by the practitioners
responsible for recruitment [7,10]. Moreover, parents may sign
consent forms and consider themselves informed without an
adequate understanding of what the study entails or how
involvement will impact upon family life [7,10]. Ensuring parents
make an informed decision about their child’s participation in a
trial is a challenge for practitioners [11–13].
Investigations of parents’ interpretations of trials frequently
identify ‘misunderstandings’, which, it is anticipated, can be
remedied by improvements to written information provision
[14,15], sufficient time for participants to consider the information
[16], and education for them and trial recruiters [7,15,17].
Parental misunderstandings most commonly arise in relation to
the purpose of the trial, randomisation, eligibility and lack of
equipoise [12,18–21]. However, even when interventions are put
in place to address misunderstandings, people will still interpret
information in complex and unexpected ways, informed by their
own priorities, belief systems, and trust in the practitioner. This
raises questions regarding how far people’s interpretations can be
altered to match those conventionally expected by the research
community [11]. Masty and Fisher describe a goodness-of-fit
approach, whereby researchers design consent procedures in ways
that are tailored to participants’ priorities and well-being. In such
an approach, a recruiter would focus on the issues that are of
concern to potential participants, as well as aiming to help
potential participants achieve the understanding of a trial that is
conventionally expected by the research community [22].
Such a tailored or parent-centred approach may help to address
the difficulties parents have in understanding trials, yet there is
little evidence on what information parents consider important
when they are approached about a trial and how well they
understand this information. This study aimed to address this gap
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in the evidence-base by exploring what issues parents consider to
be important in making a decision about their child’s participation
in a clinical trial and parents’ comprehension of these prioritised
elements. For example, randomisation is commonly misunder-
stood [23]. However, do parents consider having an understand-
ing of randomisation to be important and would a fuller
understanding assist their decision making? Giving more attention
to information that parents deem important may assist practition-
ers’ recruiting to paediatric clinical trials by focussing on
information that parents are most interested in, and which they
will therefore be motivated to engage with.
We chose a qualitative approach in order to explore parental
perspectives and decision-making during clinical trial recruitment.
Importantly, we designed our qualitative study to compare what
was said during trial recruitment discussions (which routinely take
place before practitioners seek parental consent for a trial) with the
interpretations that parents took away from these discussions. We
therefore collected recordings of parent-practitioner clinical trial
discussions as well as parent-researcher interviews.
Methods
Ethics Statement
A UK National Health Service ethics committee gave approval
for the study (Northwest 5 Research Ethics Committee: 07/
MRE08/6). Signed informed consent was obtained from all
participants.
Study Design
Our qualitative interview and observational study (called
RECRUIT) ran alongside four diverse placebo-controlled, dou-
ble-blind randomised clinical trials of medicines for children. Data
triangulation based on comparisons of transcribed audio record-
ings of i) parent-practitioner recruitment discussions and ii)
interviews with parents was used to examine recruitment processes
with the aim of identifying strategies to improve clinical trial
recruitment [24]. We selected trials to represent different
conditions, disease status, design and recruitment procedures to
maximise the transferability of findings and thereby inform
strategies for optimising recruitment to children’s clinical trials
[25,26]. The trials comprised: MASCOT (Management of asthma
in school children on therapy); MENDS (Use of melatonin in
children with neuro-developmental disorders and impaired sleep);
POP (prevention and treatment of steriod-induced osteopaenia in
children and adolescents with rheumatic diseases); and TIPIT
(Randomised controlled trial of thyroxine in pre-term infants
under 28 weeks’ gestation). For logistical reasons, sites for inclusion
in RECRUIT were generally selected from Northwest England.
Recruitment approach and timing varied in all four trials. For
example, TIPIT was initially introduced to parents by a
practitioner, usually on the neonatal unit or at the mother’s
bedside by a research nurse. In MASCOT, the initial approach
was usually via letter from the GP or by a doctor when the child
was attending a secondary care centre. Interested families received
Participant Information Leaflets (PILs) and a telephone call from a
research nurse before attending an appointment specifically
arranged to discuss trial entry. Sociodemographic information
was collected through the use of parents’ postcodes to calculate
Index of Multiple Deprivation Scores (IMD) which indicate and
rank levels of social deprivation in small geographical areas across
the UK [27].
In sampling participants we used a mix of consecutive and
purposive sampling. We used consecutive sampling initially to
minimize potential gatekeeper selection bias, whereby practition-
ers may have selected families to avoid approaching based upon
anticipated communication difficulties [28]. As the study pro-
gressed we increasingly used purposive sampling with the aim of
ensuring that parents from each of the trials were represented and
that those who declined, withdrew or who were ineligible for the
trials were included, in addition to those who remained in the trial.
A breakdown of sample trial trajectories are presented in Table 1.
All families who had participated in audio recorded parent-
practitioner trial discussions were invited to take part in interviews
(except where a child had died or we could not contact the family)
to help ensure that the sample variation represented in the trial
discussion data was also reflected in the interview data. Impor-
tantly, this allowed us to link and compare data from both sources
(i.e. patient-practitioner trial discussions and interviews) within
cases and thereby, for example, to explore how a parent’s
understanding of a trial might be associated with the way that the
trial was explained during the discussion with a practitioner [29].
Research Team and Data Collection
Interviews were conversational, yet structured around a topic
guide that covered areas which our review of literature and
steering group members had indicated were pertinent. The topic
guide was refined over the study course. Interviews were
participant led to ensure that the content reflected their own
priorities and the researchers aimed to explore participants’
perspectives in a way that avoided influencing, ‘testing’ or altering
their beliefs about the trials. Respondent validation was used
whereby previously unanticipated topics were added and discussed
with participants as interviewing and analysis progressed [30].
Researcher notes were used to assist this process [29]. Topics
included: the experience of trial recruitment from the perspective
of parents; how they felt about the trial discussions; written and
verbal information exchanged; whether any of this information
was unclear; and whether anything might have been handled
differently. See Shilling and colleagues 2011 (Text S2) [25].
Practitioners briefly explained RECRUIT to families who were
eligible for each of the four trials before seeking verbal consent
from parents to record the trial discussions and provide their
contact details to the RECRUIT team. Semi-structured interviews
with families were conducted by experienced interviewers VS and
ES, who were psychologists with interests in clinical communica-
tion and clinical trial recruitment. Neither had any prior
relationships with participants and no persons other than family
members were present during the interviews. RECRUIT inter-
viewers explained the study in more detail, including that its
purpose was to identify ways to enhance the process of recruitment
to children’s clinical trials. They also explained their independence
Table 1. Demographic and trial participation trajectory of
parents.
MASCOT MENDS POP TIPIT
N (% of 41) 6 (14.6) 15 (36.6) 8 (19.5) 12 (29.3)
N Randomised 4 9 8 11
Decline trial 0 1 0 1
Ineligible for trial at consent 1 1 0 0
Ineligible for trial after run in 1 3 N/A N/A
Withdrawn from trial 0 1 0 0
(N = 41 families).
doi:10.1371/journal.pone.0067352.t001
Parents’ Agendas in Clinical Trial Recruitment
PLOS ONE | www.plosone.org 2 July 2013 | Volume 8 | Issue 7 | e67352
from the trial and steps to ensure the confidentiality of the data
before obtaining written consent from families who wished to
participate. Practitioners securely sent audio recordings of the trial
discussions to the RECRUIT team only after signed consent had
been obtained from participants for the recordings to be released
to the RECRUIT team. Audio recordings of trial discussions from
parents who did not provide written consent were destroyed. Field
notes were made by the researcher after each interview to assist
analysis and interpretation. Parent-practitioner trial recruitment
discussions and parent-researcher semi-structured interviews were
digitally audio-recorded, transcribed verbatim, and checked and
anonymised by VS and ES. We (KW, VS and BY) analysed
transcripts of the parent-practitioner trial recruitment discussions
alongside transcripts of semi-structured interviews.
Analysis
Analysis was broadly interpretive and iterative, referring back
and forth between the developing analysis and new data for
evidence of families’ priorities, experiences and accounts of
understanding when approached about a trial [31,32]. Themes
were therefore inductively derived from the data. Whilst analysis
was informed by the constant comparison approach of grounded
theory, the focus was modified to fit with the criterion of catalytic
validity, whereby findings should be relevant to future research
and practice [31,33]. KW led the analysis and development of
coding framework with assistance from VS and BY to enable
investigator triangulation, and using QSR NVivo 9 software to
assist in the organisation and indexing of coding and transcripts.
KW read trial discussion and interview transcripts several times to
compare within and between transcripts [31,32]. Data triangula-
tion was part of this process whereby she also compared interview
data with trial discussion data. In particular, KW identified the
issues that parents viewed as important when making a decision
about a trial by systematically searching trial discussion and
interview data for the questions asked by parents, the concerns
that they voiced regarding their child’s participation in a trial and
by examining parents’ interview accounts of their decision making
process. Potential misunderstandings were identified by KW and
VS by searching parents’ interview transcripts for descriptions or
explanations that were not consistent with the trial rationale or
methodology. We then cross-referenced these with transcripts
from recorded trial discussions to examine whether the source of
the misunderstanding could be potentially linked to the trial
discussion. Potential important issues (which we refer to as ‘agenda
items’) and misunderstandings were linked together by comparing
and contrasting themes identified under each heading. The
developing analysis and coding framework was discussed in detail
with BY, who also read several of the transcripts. Detailed reports
of the findings were reviewed and commented upon by all authors
to help ‘test’ the analysis and ensure its rigour [29]. The quality
and validity of developing analysis was examined by exploring the
connection between emerging findings and the wider literature
[24,30]. Brief data extracts are provided in the main text of the
results section and in illustrative tables to evidence our interpre-
tations of participant accounts. Counts for each identified theme
are presented in Tables 2 and 3 to make explicit the basis for
conclusions drawn [34]. Data saturation was achieved with regard
to parental agendas (Table 2). However, in terms of parental
comprehension and the different types of misunderstanding that
may arise linked to agenda items (Table 3), our data were more




A total of 95 families were approached by practitioners to
participate in RECRUIT (65 approached for recorded discussion,
30 for interview without recorded discussion). Sixty families
participated in RECRUIT (41 with recorded trial discussions, 19
without). Five families with recorded trial discussions were not
approached for interview due to bereavement or contact
difficulties (e.g. as they had been transferred to another hospital
or did not respond to invitations). A further 30 families declined
the study, either by direct refusal or by not arranging or cancelling
appointments and not responding to further contacts from the
research team. Families were not asked for their reasons for
declining RECRUIT.
Of the total RECRUIT sample, 41 families had both recorded
trial discussion and interview data, which were matched for
analysis in this paper. Eleven practitioners were involved in the
audio recorded trial discussions; of these 2 were research nurses
and 9 were doctors. Table 1 indicates the numbers of families
participating by trial and trajectory. The process of recruitment to
Table 2. Parents’ agenda items identified in trial recruitment discussions and interview analysis.
Agenda item
Number of parents referring to agenda item
during interviews
Number of parents referring to agenda item in trial
recruitment discussions
Clinical benefit (16) (3)
Safety (15) (5)
Practicalities of participation (12) (4)
Research for the common good (12) (0)
Access to medication (9) (4)
Randomisation (7) (1)
Contraindication (6) (1)
Showing gratitude to practitioner (6) (0)
Practitioner opinion (5) (0)
Child’s wishes (4) (0)
Trial purpose (0) (3)
(N = 41 families).
doi:10.1371/journal.pone.0067352.t002
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clinical trials often involves several discussions between practition-
ers and potential participants. For 18 of the families (44%) in our
study, the initial trial discussion that a family had with a
practitioner was recorded. These were face to face discussions in
which trial information was provided to families. The remaining
23 (56%) families had previously been given brief details of the
trial by a practitioner, either over the telephone (19, 83%), or in
person at a previous hospital visit (4, 17%). Recordings for these
families relate to a subsequent face to face discussion with a
practitioner in which information about the trial was presented.
The initial trial discussions for these families were not recorded.
Across all data included in the current analyses, there were eight
instances where both parents were present for trial discussions
(19.5%) and two instances where fathers were present at semi-
structured interviews as well as mothers (5%). Only one member of
the research team was present during the semi-structured
interviews with parents; in a few instances, where it was
unavoidable, a child (trial candidate or younger sibling) was
present during the interviews. Interviews took place in the family
home (n= 32, 78%), hospital site (n = 7, 17%) or via telephone
(n = 2, 5%), occurred a mean of 42 days after the recorded trial
discussion (range 14–126) and lasted approximately 45 to 60
minutes. As shown in Table 1, of the 41 families, 33 were
randomised, though 1 later withdrew from the trial. Four
consented but were ineligible after run in, 2 were ineligible for
the trial at consent and 2 declined the trial. Interviews took place
between March 2008 and January 2010.
The range of Index of Multiple Deprivation ranks (2007) in this
sample was 1–30,591 with median rank 3560 and interquartile
range 1366–10705 (where 1 is the highest level of deprivation).
This excludes three families from Northern Ireland where
deprivation scores are not directly comparable. Twenty four of
the 38 (63%) families were in the lowest quintile (highest
deprivation); only 3 were in the highest.
Parents’ Agenda Items
We labelled the issues or topics that parents seemed to regard as
important in making a decision about their child’s participation in
a clinical trial as ‘agenda items’. Parents had many questions and
concerns about trial participation that they raised spontaneously in
their interviews when the researcher asked them to describe the
trial consent procedure or design. As the following quote
illustrates, parents placed importance upon issues such as child
safety, which influenced their decisions about trial participation:
‘‘If it involved [child name] taking part and it didn’t hurt them then yeah, by
all means, go for it, do it, but if it hurts [child name] then I’d disagree with
it completely’’ (Male 2). Agenda items were evident in parents’
descriptions of decision making for all four trials.
As Table 2 shows the most common agenda items raised were a
desire for their child to benefit from participation in the trial
(clinical benefit): ‘‘Yeah he can…. yeah take part yeah because I want…. I
basically want him to like sleep, you know, have a good night’s sleep’’.
(Female 6, trial discussion), and concerns about whether their child
would be harmed by participation (safety) ‘‘So he wouldn’t become
addicted to it?’’ (Female 4, trial discussion). The practicalities of
participation concerned parents, such as difficulties with children
not wanting to take medicine: ‘‘It’s really hard getting medication down,
really hard’’. (Female 1, trial discussion). Parents described how
research to benefit children in the future (research for the common
good) had influenced their decision to participate: ‘‘So as long as it
can help in the future, other babies, then I’m really up for it’’. (Female 31,
interview). Gaining access to medication for their child was also
discussed: ‘‘I’d heard about ,name of trial drug. and I’d read a few things
on the internet, because of ,child’s name. sleeping, and I just thought, right
I’m going to ask if he can have it’’ (Female 8, interview). Randomisation
was an issue for some parents, as indicated by their comments that
the process could mean that their child would receive a placebo
rather than the trial drug: ‘‘We had to weigh it up against the fact that….
it could be a placebo anyway, it might not be the ,trial medication.’’.
(Female 24, interview).
Parents also questioned whether the trial medication could be
taken alongside their child’s medication regime (contraindication)
‘‘The questions that I’ve got to ask are just related to ,child’s name. epilepsy
really and just because we’ve had no seizure since his surgery in January…I
think that’s our only sort of concern…how it’s gonna maybe interfere, with
,non trial medication.’’ (Female 6, trial discussion). For some
parents showing gratitude to a practitioner was important: ‘‘I just
thought after everything they’ve done for us we can’t not, you know, give
something back to them’’ (Female 8, interview), whilst others pointed to
a sense that they might be influenced by a practitioner’s opinion
on whether their child may benefit from entering the trial: ‘‘If a
doctor did turn around and say to me…‘This is what I think you’d benefit
from, this is what I think …’, you know, ‘… the child would benefit from and
I think it’s a very good idea’ then the doctor could probably make my mind up
for me actually’’ (Female 1, interview). To a lesser extent parents
described how their child’s wishes were important and how they
had involved them in the decision making process: ‘‘I always think
it’s best to be upfront with your kids, no matter what, to a level of their
understanding…I mean, at nine, he’s old…he is old enough to say, well, you
Table 3. Parent misunderstandings linked to important issues as identified in the interviews.
Misunderstandings (number of parents) Example quotations
Context of misunderstanding shown in
quotation
Believed clinical benefit (8) ‘‘I’ve been looking for something to help with her
sleep problem for a long, long time.’’ (Female 24)
Clinical benefit could not be guaranteed by
participation in the trial.
Access to medication (8) ‘‘I’ve got sort of a 50/50 chance of either she gets
the drug or she gets the placebo. But she wouldn’t
be getting it otherwise’’. (Female 24)
Medication was available outside the particular trial.
Randomisation (3) ‘‘I wonder who does actually makes the decision,
who goes on what and who doesn’t’’. (Female 1)
Computer randomisation. No person involved in
making a decision.
Practical implications of trial procedures (3) ‘‘[Doctor] told me, I think, they’re going to put like
kind of a small tube inside him…I just didn’t like the
idea from the beginning so I didn’t give it more
attention’’. (Female 34)
The trial medication was to be administered by a
catheter already being used to administer drugs
to the child.
(N = 41 families).
doi:10.1371/journal.pone.0067352.t003
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know, I don’t really fancy it’’ (Female 18, interview). Finally, the
purpose of the trial was questioned by some ‘‘And what are you looking
for in that?’’ (Male 4, trial discussion). All parents had at least one
agenda item, whilst some had multiple agenda items that informed
their decision making, ‘‘You just work out what […] you know, what
happens? Will she be able to cope with it? Will it be beneficial to her or to
others? And then, okay, yes, we’ll do it or not’’ (Male 14).
As shown by the differences in frequencies of parents referring
to themes displayed in Table 2, agenda items were mainly
discussed during the parent-researcher interviews, rather than in
recorded trial discussions. For example, during interviews 12
parents discussed issues related to the practicalities of trial
participation, such as administering medicine to children. This
agenda item was only raised by four parents during trial
discussions.
Parents’ Misunderstandings Linked to Agenda Items
Parents often spoke of having a sense of confusion or poor
recollection about the trial, which they linked to their emotional
situation or being overloaded with information at the time of
recruitment, but without specifying the particular issues they
misunderstood, ‘‘There was like a week of seeing everybody. And when they
were coming back asking us do […] do you remember going into the POP trial
and I’m thinking no, you know, I don’t remember anything’’ (Female 25).
Three parents in the TIPIT trial told the researchers that they
were comfortable with the limitations of their understanding
because they felt that their baby was safe, ‘‘I don’t understand a lot of
the medical terms and things, but I know it’s not harming him or anything, so
for me, you know, I was like, go ahead with it’’ (Female 41). However,
there were cases in all four trials where parents had specific
misunderstandings, which had the potential to influence their
decisions on trial entry (Table 3).
Perceived clinical benefit and access to medication were the
most frequent parental misunderstandings. Regarding clinical
benefit, parents, particularly from the TIPIT and MENDS trials,
did not speak of the trial as having been designed to test whether
or not the trial medication was beneficial to a group of children.
Regarding access to medication, some parents in the MENDS trial
were not aware that the trial drug was available outside the trial
and only participated to access the drug, ‘‘We’d already made our mind
up that we were going to. Before we’d even got the information […] we just
weren’t getting sleep […] it’s like, we have to do something’’ (Female 22).
We labelled accounts of clinical benefit as misunderstandings
only when parents (n = 8) emphasised a sense of certainty that their
child stood to benefit from trial medication: ‘‘if he does get the ,Name
of trial drug. on this trial it will help him have a good night’s sleep’’ (Female
4). Other parents spoke of how they hoped their child would benefit
(n = 7) and seemed to understand that there was a 50:50 chance of
getting the trial medication: ‘‘I was just thinking I hope he gets the
,Name of trial drug. one’’ (Male 5). We did not label these accounts
of hope for clinical benefit as misunderstandings because such
hope is compatible with the rationale for conducting a clinical
trial. In any event, such comments did not represent a direct
misunderstanding of what parents had been told in the clinical trial
discussions in the sense that practitioners often began trial
discussions by mentioning previous research indicating the
potential benefits of the trial medication.
Despite many practitioners clearly explaining how the rando-
misation process worked, some parents were confused. For
example, some mistakenly believed that practitioners made the
decision about which arm of the trial their child was allocated to,
rather than allocation being conducted by computer randomisa-
tion: ‘‘I wonder who does actually makes the decision, who goes on what and
who doesn’t’’ (Female 1). Finally, parents were concerned that trial
procedures would be burdensome. Some parents only became
aware of certain trial procedures during the course of the trial,
whilst one parent declined the trial because she mistakenly
believed that it involved extra invasive procedures (see Table 3).
The trial medication was to be given through lines already in use
to feed the baby, but this was insufficiently explicit in the trial
discussion: ‘‘It’s called err a syringe pump basically, which is, you know,
puts medicine to the veins’’. (Practitioner 2, trial discussion).
Discussion
Our study has illuminated parents’ agendas when making a
decision about participation in a paediatric clinical trial. Some of
these agendas, including safety, trial purpose, practicalities of
participation and randomisation, overlap with those convention-
ally prioritised by the research community [12,17,23,36]. How-
ever, other agenda items, such as access to medication, clinical
benefit, showing gratitude to a practitioner and practitioner
opinion, differ from those prioritised by the research community.
Our study provides additional evidence about what parents
consider important when making a decision about a clinical trial
[36]. However, perhaps its most significant contribution is in
drawing attention to how parents’ agendas were often overlooked
during interactions with practitioners. We also provide new
evidence about how parents’ agendas were associated with specific
misunderstandings, which in turn have the potential to influence
parents’ decisions about a trial.
While some parental misunderstandings appeared to be linked
to how practitioners had explained the trials, importantly, we also
found that even when practitioners’ descriptions were clear,
parents sometimes incorrectly interpreted the information provid-
ed. Moreover, our study showed how parents did not commonly
seek clarification from practitioners or express their queries or
concerns during the discussions that form a routine part of
recruitment to most paediatric trials. Relational decision making
was evident, as parents valued practitioner opinions, they trusted
their judgement and made decisions without engaging with the
finer details of the trial [37,38]. Parents said little during the trial
discussion and practitioners asked few open-ended questions,
preventing the identification of misunderstandings [25]. Many of
the parents’ questions and concerns only became apparent during
the subsequent parent-researcher interviews.
Encouraging more parental participation in the discussions may
help practitioners identify key issues and concerns for parents and
provide appropriate information and clarification. Our study
points to the potential benefits of practitioners tailoring informa-
tion to what parents deem important as well as to the conventions
of the research community [22,36,39]. However, as parents
prioritised showing gratitude, practitioners may need to explain
that parents should not feel obligated to participate because of the
care their child received [40,41]. In indicating that parents’ role in
recruitment discussions was somewhat passive, our findings stand
in contrast to previous literature which has characterised parents
as taking an active role in recruitment discussions, and as valuing
the ability of practitioners to listen to the questions and concerns of
parents [42]. However, whereas previous research has tended to
rely exclusively on parental reports of their experiences of
recruitment, we also had access to recordings of trial recruitment
discussions.
In line with previous literature, some parents were subject to the
‘therapeutic misconception’ as their decisions about trial entry
were influenced by a belief that their child would benefit from trial
medication [15,19,43]. However, we did not regard those who
simply hoped that their child would benefit as having misunder-
Parents’ Agendas in Clinical Trial Recruitment
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stood the purpose of the trial – after all, no trial would be
conducted unless there was reason to hope that it might offer
clinical benefit. Parents understandably prioritised their child’s
wellbeing and would only enter a trial if they felt their child would
not be harmed; this included requiring reassurance that trial
medication could be taken alongside other medication. Practical
implications of involvement were important to parents, yet
incorrect interpretations about trial procedures and protocol
meant that parents declined unnecessarily or were not fully aware
of what the study entailed [7,10]. These types of misunderstand-
ings have the potential to leave parents with negative views about
research and impact upon trial enrolment and retention.
Addressing these is a challenge for practitioners in conducting
trials and evidence-based medicine in paediatrics as a whole.
Providing parents with sufficient time to digest written trial
information and ensuring opportunities to ask further questions at
a later date may further help to improve their understanding
[15,16]. However, parents may struggle to voice or formulate
questions [44–47], which is understandable given that research
will be a topic that is new to many. In our study practitioners asked
parents few open-ended questions and parents initiated few
questions, indicating the need to improve communication during
trial discussions in order to identify and address parents’
misunderstandings [7,25]. Others have suggested that this might
include asking parents to describe their understanding of the trial
in such a way that these are not perceived to be a ‘test’, such as: ‘I
need to check that I have made everything clear enough. Could
you tell me what you have understood?’ [10,48] Alternatively,
practitioners could simply ask parents open-ended questions and
use prompts to invite opinions about the trial and explore
understanding [10,16,49,50]. Our findings suggest that such
questions or prompts should cover a range of different issues, as
parents in our study often had more than one agenda item.
Practitioners might also assist parents by making simple adjust-
ments to the way they invite questions (e.g. by ‘scaffolding’ their
question invitations around particular aspects of the trial) and by
linking their question invitations to the parental priorities
identified in this study [51]. Author derived question examples,
which could be used to assist communication during trial
discussion are presented in Table 4. Question invitations could
also be adapted to suit the individual trial and to help structure a
recruitment interaction with a parent or child to assist commu-
nication and improve understanding [21,22].
Further research is necessary to establish the effectiveness of
these suggestions in assisting communication and parental
understanding in paediatric clinical trial recruitment. Similarly,
research is required to investigate alternative ways of presenting
trial information outside of the recruitment discussion to address
parental questions and concerns that may only become apparent
to them after they have had time to reflect on the trial discussion,
or when parents do not wish to directly ask a practitioner. Online
formats such as web based forums and the use of social networking
sites may also enable on going communication between parents
and practitioners over the life of a trial [52], yet their feasibility
and effectiveness is not known.
Limitations
The study had some limitations. Mothers were over-represented
in the sample as fathers were either not present in recorded trial
discussions or did not participate in interviews. As a result,
potential gender differences in the agendas and understanding of
parents could not be explored. As gender has been shown to affect
communication between patient and practitioners, with female
patients receiving more information and asking more questions
than males [53,54], further research is needed to investigate
fathers’ priorities and understanding of clinical trials. The impact
of practitioner gender upon parent-practitioner communication
and parental understanding should also be explored [55].
Although parents were accessed through multiple centres, the
sample was weighted towards areas of higher material deprivation
and participating hospitals were located in urban city centres. It
was therefore not possible to fully explore potential differences in
agenda items or levels of communication in parents from less
deprived areas. Further research is required to fully explore links
between material deprivation and geographical location and
parental agenda items. While parents and practitioners may have
several discussions about a trial, it was only possible to record one
of these discussions for each family and this may have constrained
our interpretations. In particular, it is possible that parents’
agendas were focussed upon issues during trial discussions that we
did not audio record. However, relatively few studies of paediatric
clinical trials have accessed trial discussions at all, with the result
that these interactions have remained a ‘‘black box’’ thereby
limiting the development of knowledge about how communication
about clinical trials goes awry and how to enhance it [39].
Moreover, in recording both initial and subsequent discussions we
have provided insights into parental agendas and misunderstand-
ings at both time points. Quantification in social research has been
subject to much debate [56,57]. Our inclusion of frequencies (in
Tables 2 and 3) for themes identified in qualitative analysis served
Table 4. Invitations to elicit parents’ questions in parent-practitioner discussions about clinical trials.
Question
1 Based upon the information we have given you, what’s your opinion about this study?
2 I need to check that I have made everything clear enough. Could you tell me what is the purpose of this study?
3 Is there something you would like to ask me about the potential risks of the study?
4 Do you have some concerns about how taking part in the study may impact upon your child’s daily routine?
5 Do you have some questions about any medication that your child is currently taking and whether this needs to be reviewed if your child takes part in the study?
6 Do you foresee problems with administering the medication?
7 Have you had chance to talk to your husband/partner or a family member about the study?
8 Could you tell me whether you think your child may benefit from taking part in the trial?
9 Would you like me to go over again how children are placed into different groups to find out if this medicine/medical device is effective?
10 Is there anything you are worried about or would like me to go over again?
doi:10.1371/journal.pone.0067352.t004
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to illustrate our interpretations and verify the basis for conclusions
drawn [34]. However, these frequencies should be interpreted with
caution. Whilst we incorporated four trials representing different
conditions, disease status and designs to help maximise the
transferability of findings we acknowledge that quantitative
research is necessary to examine the wider generalizability of
our conclusions. Data saturation was reached in terms of parent
agendas. However despite our sample being relatively large for a
qualitative study, our data on misunderstandings was more limited
and saturation was not fully achieved. As other qualitative
researchers have also described, resource constraints limited our
ability to continue sampling in order to reach saturation for all
categories [35]. We described variations and similarities in agenda
items and misunderstandings within and between trials where
appropriate, yet further research is required to explore agenda
items and misunderstandings amongst parents’ recruited to
different trials and settings (e.g. trials conducted in paediatric
emergency care). Finally, our sample included few parents who
had declined or withdrew or were ineligible for trials, insight into
the agendas and misunderstandings amongst such groups of
parents are needed to inform future recruitment practice.
Conclusions
Our findings provide insights into parents’ agendas when
making a decision about a clinical trial, evidence that their
agendas often remain unvoiced in discussions with practitioners, as
well as indicating the misunderstandings that can arise around
parental agendas. These insights can be used by practitioners to
structure trial recruitment discussions. Improved communication
between practitioner and parent tailored to the needs and
concerns of parents may improve recruitment practice and
ultimately benefit evidence-based paediatric medicine.
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